DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Oxandrin (Oxandrolone) - Summary

 


Nutrilib.com
A comprihensive source of nutritional information

OXANDRIN SUMMARY

OXANDRIN® oral tablets contain 2.5 mg or 10 mg of the anabolic steroid oxandrolone.

Oxandrin is indicated as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma, and in some patients who without definite pathophysiologic reasons fail to gain or to maintain normal weight, to offset the protein catabolism associated with prolonged administration of corticosteroids, and for the relief of the bone pain frequently accompanying osteoporosis (See DOSAGE AND ADMINISTRATION).


See all Oxandrin indications & dosage >>

OXANDRIN NEWS HIGHLIGHTS

Published Studies Related to Oxandrin (Oxandrolone)

The effects of oxandrolone and exercise on muscle mass and function in children with severe burns. [2007.01]

Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial. [2006.03]

Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study. [2006.03]

Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment. [2005.09]

Oxandrolone does not improve outcome of ventilator dependent surgical patients. [2004.09]

more >>

Clinical Trials Related to Oxandrin (Oxandrolone)

Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions [Completed]

Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer [Active, not recruiting]

Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome [Active, not recruiting]

The Use of Anabolic Steroids to Improve Function After Spinal Cord Injury [Completed]

Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD) [Completed]

more >>

Page last updated: 2007-02-12

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008